Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study
暂无分享,去创建一个
G. Ciliberto | M. Marino | G. Blandino | A. Sacconi | M. Rizzo | I. Terrenato | A. Mengarelli | S. Donzelli | M. Spagnuolo | C. Ercolani | A. di Benedetto | F. Palombi | G. Regazzo | F. Marchesi